Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients-Reference-Cited by-同舟云学术

Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients

Published:2013-06-20 Issue:7 Volume:24 Page:1151-1158
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Brookhart M. Alan,Freburger Janet K.,Ellis Alan R.,Wang Lily,Winkelmayer Wolfgang C.,Kshirsagar Abhijit V.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference35 articles.

1. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%.;Collins;J Am Soc Nephrol,2001

2. Iron supplementation to treat anemia in patients with chronic kidney disease

3. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

4. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease

5. The DOPPS Practice Monitor for US Dialysis Care: Trends Through April 2011

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose intravenous iron use in hemodialysis patients: Results from the National Health Insurance System (2019–2020) in South Korea;2024-06-06

2. Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction;International Journal of Molecular Sciences;2024-03-27

3. Zinc Supplementation Enhances the Hematopoietic Activity of Erythropoiesis-Stimulating Agents but Not Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitors;Nutrients;2024-02-13

4. Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach;International Journal of Epidemiology;2023-02-11

5. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism;International Journal of Molecular Sciences;2023-02-03